Finding useful biomarkers for Parkinson s disease

Alice S. Chen-Plotkin, Roge Albin, Ro Alcalay, Debr Babcock, Vikra Bajaj, Duboi Bowman, Ale Buko, Jess Cedarbaum, Danie Chelsky, Mar R. Cookson, Te M. Dawson, Richar Dewey, Tatian Foroud, Mar Frasier, Dwigh German, Katrin Gwinn, Xueme Huang, Catherin Kopil, Thoma Kremer, Shirle LaschKe Marek, Jarro A. Marto, Kalpan Merchant, Bri Mollenhauer, Ann Naito, Judit Potashkin, Alyss Reimer, Lian S. Rosenthal, Rache Saunders-Pullman, Clemen R. Scherzer, Tod Sherer, Andre Singleton, Margare Sutherland, Ine Thiele, Marce Van Der Brug, Kendall Van Keuren-Jensen, Davi Vaillancourt, Davi Walt, Andre West, Jin Zhang

Research output: Contribution to a Journal (Peer & Non Peer)Review articlepeer-review

97 Citations (Scopus)

Abstract

The recent advent of an ecosystem of shared biofluid sample biorepositories and data sets will focus biomarker efforts in Parkinson s disease, boosting the therapeutic development pipeline and enabling translation with real-world impact.

Original languageEnglish
Article numbereaam6003
JournalScience Translational Medicine
Volume10
Issue number454
DOIs
Publication statusPublished - 15 Aug 2018
Externally publishedYes

Cite this